Evaluating breast cancer predisposition genes in women of African ancestry.

[1]  James M. Hodge,et al.  A Population-Based Study of Genes Previously Implicated in Breast Cancer. , 2021, The New England journal of medicine.

[2]  B. Karlan,et al.  Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  Jaana M. Hartikainen,et al.  Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. , 2021, The New England journal of medicine.

[4]  F. Couch,et al.  Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women. , 2020, Journal of the National Cancer Institute.

[5]  Tariq Ahmad,et al.  A structural variation reference for medical and population genetics , 2020, Nature.

[6]  J. Long,et al.  Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women , 2020, Breast Cancer Research and Treatment.

[7]  Julie O. Culver,et al.  Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D , 2020, Journal of the National Cancer Institute.

[8]  M. García-Closas,et al.  Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population‐based case–control study , 2019, International journal of cancer.

[9]  J. Long,et al.  Discovery of a Pathogenic Variant rs139379666 (p. P2974L) in ATM for Breast Cancer Risk in Chinese Populations , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[10]  A. Jemal,et al.  Cancer statistics for African Americans, 2019 , 2019, CA: a cancer journal for clinicians.

[11]  T. Walsh,et al.  Inherited Breast Cancer in Nigerian Women , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Chunlei Liu,et al.  ClinVar: improving access to variant interpretations and supporting evidence , 2017, Nucleic Acids Res..

[13]  Raymond Dalgleish,et al.  VariantValidator: Accurate validation, mapping, and formatting of sequence variation descriptions , 2017, Human mutation.

[14]  Robert Huether,et al.  Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer , 2017, JAMA oncology.

[15]  Keith Nykamp,et al.  Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria , 2017, Genetics in Medicine.

[16]  John Kidd,et al.  Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  K. Nathanson,et al.  Population Frequency of Germline BRCA1/2 Mutations. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  P. Ng,et al.  SIFT missense predictions for genomes , 2015, Nature Protocols.

[19]  A. Monteiro,et al.  A high frequency of BRCA mutations in young black women with breast cancer residing in Florida , 2015, Cancer.

[20]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[21]  X. Shu,et al.  Interactions of Hormone Replacement Therapy, Body Weight, and Bilateral Oophorectomy in Breast Cancer Risk , 2014, Clinical Cancer Research.

[22]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[23]  Jana Marie Schwarz,et al.  MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.

[24]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[25]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[26]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[27]  J. Haines,et al.  Genome-wide association study identifies a novel breast cancer susceptibility locus at 6q25.1 , 2009, Nature Genetics.

[28]  Giovanni Parmigiani,et al.  Meta-analysis of BRCA1 and BRCA2 penetrance. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[30]  L. Esserman,et al.  Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. , 2005, JAMA.

[31]  W. Zheng,et al.  Southern community cohort study: establishing a cohort to investigate health disparities. , 2005, Journal of the National Medical Association.

[32]  D. Altshuler,et al.  The multiethnic cohort study: exploring genes, lifestyle and cancer risk , 2004, Nature Reviews Cancer.

[33]  M. King,et al.  Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2 , 2003, Science.